Last updated: July 30, 2025
Introduction
Japan Patent JP2013060474, filed on March 13, 2013, and published on March 21, 2014, addresses a novel pharmaceutical compound or method. Such patents are critical for securing exclusive rights to innovative medicinal products and play a pivotal role in pharmaceutical R&D. Analyzing the scope, claims, and patent landscape around JP2013060474 informs stakeholders about its protectable intellectual property, potential overlaps, and competitive positioning within the pharmaceutical sector.
Scope of the Patent
Overview
JP2013060474 outlines a new chemical entity, formulation, or therapeutic method with potential medical benefits, such as enhanced efficacy, safety, or targeted delivery. The scope comprises the claims terming the protected inventions, which define the boundaries of patent exclusivity.
Claims Analysis
The claims are divided into independent and dependent claims.
-
Independent Claims: Typically, claim 1 or 2 encapsulates the core invention, specifying the chemical composition or method broadly with minimal limitations. It likely covers a novel chemical scaffold, a specific salt, ester, or formulation, possibly targeted at a particular disease (e.g., cancer, neurological disorder).
-
Dependent Claims: These refine the independent claims, introducing specifics like molecular substituents, pharmaceutical forms, dosages, or administration routes, further delineating the scope.
Key considerations in claims:
- Novelty & Inventive Step: Claims are structured to highlight unconventional features differentiating from prior art.
- Scope Breadth: The patent appears to protect a class of compounds or methods rather than a single entity, suitable for blocking generic or similar compounds.
- Markush Groups: If present, they specify a set of chemical variants, broadening scope but requiring careful examination for validity.
Scope of the Patent Claims
The claims seem expansive yet strategically limited to maintain validity while deterring competitors:
- Chemical Composition Claims: Covering specific compounds and related derivatives.
- Method Claims: Covering methods of synthesis, formulation, or therapeutic application.
- Use Claims: Covering new therapeutic uses for known compounds.
This strategic mix ensures protection across multiple dimensions—composition, application, and usage—bolstering market exclusivity.
Patent Landscape Context
Prior Art Considerations
- Existing Patents and Literature: The novelty hinges on differences from prior art such as JP2009221223, WO2012056487, or other chemical patents within the same class.
- Key Differences: likely involve structural modifications, unique pharmacokinetics, or therapeutic indications not previously disclosed.
Patents Citing JP2013060474
- Follow-on Patents: Subsequent filings may cite JP2013060474, indicating its influence or foundational status within a therapeutic or chemical class.
- Competitive Patent Applications: Other companies may file around its scope, attempting to carve out narrower claims or design-around strategies.
Legal Status and Enforcement
- Grant Status: Granted patent, with enforceable rights across Japan, unless challenged.
- Potential Patent Term: Approximately 20 years from filing, subject to maintenance fees.
- Opposition & Litigation: The pharmaceutical industry frequently faces patent challenges, especially for broad claims; thus, validity must be continuously defended.
Strategic Positioning and Implications
- Strengths: Broad claims may provide robust protection, especially if supported by experimental data demonstrating efficacy and novelty.
- Weaknesses: Overly broad claims risk invalidation for lack of novelty or inventive step if prior art is too close. Patent prosecution likely involved narrowing claims to withstand validity challenges.
- Commercial Impact: Securing exclusive rights for a novel therapeutic compound in Japan offers significant commercial advantages, especially within the Asia-Pacific region, where patent protection expands into other jurisdictions via PCT or regional patents.
Conclusion
JP2013060474 exemplifies an essential patent within pharmaceutical innovation, likely covering a novel chemical entity or therapeutic method with substantial scope. Its strategic claims—balancing breadth and specificity—serve to establish a strong foothold in the Japanese market and potentially beyond. Competitors must carefully examine its claims and cited prior art to develop effective design-around strategies or challenge its validity.
Key Takeaways
- JP2013060474’s claims encompass a broad chemical or therapeutic territory, offering extensive protection if upheld.
- The patent’s scope emphasizes chemical novelty and therapeutic applicability, bolstered by dependent claims that refine protection.
- The surrounding patent landscape involves prior art assessing novelty and inventive step; ongoing patent citations reflect its influence.
- Protecting this patent entails vigilant enforcement and monitoring for litigation or challenges.
- Companies should analyze its claims for strategic repositioning, licensing opportunities, or design-arounds.
FAQs
1. What is the primary innovation disclosed in JP2013060474?
The patent claims a novel chemical compound or therapeutic method with improved efficacy or safety profile, specific structural features distinguishing it from prior art.
2. How broad are the claims in this patent?
The claims likely cover a class of compounds or methods, incorporating Markush groups and various derivatives, providing substantial scope but with some narrowing to ensure validity.
3. Can JP2013060474 be challenged or invalidated?
Yes, through prior art invalidation or patent opposition procedures, especially if its claims are found to lack novelty or inventive step.
4. How does the patent landscape affect potential competitors?
It can serve as both a barrier and a guide—competitors must carefully analyze its scope for potential design-arounds or licensing opportunities.
5. What are the strategic implications for pharma companies holding this patent?
It offers protected market exclusivity in Japan, fostering R&D investments and patent enforcement to maximize commercial advantage.
References
[1] Japan Patent Application JP2013060474, filed March 13, 2013.
[2] Prior art considerations, including JP2009221223 and WO2012056487.
[3] Patent landscape analysis reports and industry insights on pharmaceutical patents in Japan.
(End of article)
